Thalidomide is a kind of medication called an immunomodulatory agent that promotes an immune response to help slow tumor growth. Thalidomide is used in the treatment of several different indications.
|Celgene Corporation, a wholly owned subsidiary of Bristol Myers Squibb
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.